These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 27998790)

  • 61. Association of a novel seven-gene expression signature with the disease prognosis in colon cancer patients.
    Yang H; Liu H; Lin HC; Gan D; Jin W; Cui C; Yan Y; Qian Y; Han C; Wang Z
    Aging (Albany NY); 2019 Oct; 11(19):8710-8727. PubMed ID: 31612869
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Construction of a Signature Composed of 14 Immune Genes to Judge the Prognosis and Immune Infiltration of Colon Cancer.
    Mo S; Pei Z; Dai L
    Genet Test Mol Biomarkers; 2021 Mar; 25(3):163-178. PubMed ID: 33734891
    [No Abstract]   [Full Text] [Related]  

  • 63. Molecular docking and machine learning analysis of Abemaciclib in colon cancer.
    Liñares-Blanco J; Munteanu CR; Pazos A; Fernandez-Lozano C
    BMC Mol Cell Biol; 2020 Jul; 21(1):52. PubMed ID: 32640984
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of a Recurrence Signature and Validation of Cell Infiltration Level of Thyroid Cancer Microenvironment.
    Zhang L; Wang Y; Li X; Wang Y; Wu K; Wu J; Liu Y
    Front Endocrinol (Lausanne); 2020; 11():467. PubMed ID: 32793117
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.
    Shan Z; Wang W; Tong Y; Zhang J
    Med Sci Monit; 2021 Mar; 27():e929558. PubMed ID: 33758160
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.
    Di Narzo AF; Tejpar S; Rossi S; Yan P; Popovici V; Wirapati P; Budinska E; Xie T; Estrella H; Pavlicek A; Mao M; Martin E; Scott W; Bosman FT; Roth A; Delorenzi M
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25246611
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
    Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
    Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of genes and pathways related to lymphovascular invasion in breast cancer patients: A bioinformatics analysis of gene expression profiles.
    Klahan S; Wong HS; Tu SH; Chou WH; Zhang YF; Ho TF; Liu CY; Yih SY; Lu HF; Chen SC; Huang CC; Chang WC
    Tumour Biol; 2017 Jun; 39(6):1010428317705573. PubMed ID: 28651487
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Analytical performance of a formalin-fixed paraffin-embedded tissue-based 634-probe prognostic assay for predicting outcome of patients with stage II colon cancer.
    Plamadeala V; Huang S; McCreary SM; Reitze NJ; Ewing AL; Gabrin MJ; Bennett AE; Mulligan JM; Wilson CL; Wang D
    Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):308-16. PubMed ID: 24717231
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transcriptome-based identification of molecular markers related to the development and prognosis of Colon cancer.
    Lu J; Chen Q
    Nucleosides Nucleotides Nucleic Acids; 2021; 40(11):1114-1124. PubMed ID: 34519615
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Confirmation of a metastasis-specific microRNA signature in primary colon cancer.
    Coebergh van den Braak RRJ; Sieuwerts AM; Lalmahomed ZS; Smid M; Wilting SM; Bril SI; Xiang S; van der Vlugt-Daane M; de Weerd V; van Galen A; Biermann K; van Krieken JHJM; Kloosterman WP; Foekens JA; ; Martens JWM; IJzermans JNM
    Sci Rep; 2018 Mar; 8(1):5242. PubMed ID: 29588449
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
    Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A 16-gene expression signature to distinguish stage I from stage II lung squamous carcinoma.
    Wang R; Cai Y; Zhang B; Wu Z
    Int J Mol Med; 2018 Mar; 41(3):1377-1384. PubMed ID: 29286069
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Classifier of cross talk genes predicts the prognosis of hepatocellular carcinoma.
    Zhai X; Xue Q; Liu Q; Guo Y; Chen Z
    Mol Med Rep; 2017 Sep; 16(3):3253-3261. PubMed ID: 28713927
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of Molecular Targets for Predicting Colon Adenocarcinoma.
    Wang Y; Zhang J; Li L; Xu X; Zhang Y; Teng Z; Wu F
    Med Sci Monit; 2016 Feb; 22():460-8. PubMed ID: 26868022
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Protein-protein interaction networks and modules analysis for colorectal cancer and serrated adenocarcinoma.
    Yu H; Ye L; Wang J; Jin L; Lv Y; Yu M
    J Cancer Res Ther; 2015; 11(4):846-51. PubMed ID: 26881529
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metabolic gene signature for predicting breast cancer recurrence using transcriptome analysis.
    Feng J; Ren J; Yang Q; Liao L; Cui L; Gong Y; Sun S
    Future Oncol; 2021 Jan; 17(1):71-80. PubMed ID: 33397130
    [No Abstract]   [Full Text] [Related]  

  • 78. Expression signature defined by FOXM1-CCNB1 activation predicts disease recurrence in non-muscle-invasive bladder cancer.
    Kim SK; Roh YG; Park K; Kang TH; Kim WJ; Lee JS; Leem SH; Chu IS
    Clin Cancer Res; 2014 Jun; 20(12):3233-43. PubMed ID: 24714775
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A molecular signature for the prediction of recurrence in colorectal cancer.
    Wang L; Shen X; Wang Z; Xiao X; Wei P; Wang Q; Ren F; Wang Y; Liu Z; Sheng W; Huang W; Zhou X; Du X
    Mol Cancer; 2015 Feb; 14(1):22. PubMed ID: 25645394
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery.
    Park YH; Jung HH; Do IG; Cho EY; Sohn I; Jung SH; Kil WH; Kim SW; Lee JE; Nam SJ; Ahn JS; Im YH
    Int J Cancer; 2015 Apr; 136(8):1976-84. PubMed ID: 25537444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.